Sildenafil Tablet, Film Coated
Product Images NDC 31722-710

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 31722-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafilchemicalstructure (Sildenafilchemicalstructure)

Chemical structure diagram of Sildenafil, showing its molecular framework with labeled functional groups and ring structures consistent with the active ingredient Sildenafil.*

FDA Label Image

Sildenafilfig1 (Sildenafilfig1)

A line graph showing the change in systolic blood pressure (SBP) in mmHg over time (hours) post dose. Two lines compare the effects of Doxazosin plus Placebo and Doxazosin plus Sildenafil 25 mg, tracking blood pressure changes from 0 to 8 hours post dose.*

FDA Label Image

Sildenafilfig2 (Sildenafilfig2)

A line graph showing the change in systolic blood pressure (SBP) in mmHg over time post dose (hours) comparing Doxazosin with placebo and Doxazosin with Sildenafil 25 mg. Two lines depict trends for each treatment group from 0 to 8 hours post dose.*

FDA Label Image

Sildenafilfig3 (Sildenafilfig3)

A line graph showing the change in systolic blood pressure (SBP) in mmHg over time in hours post-dose. Two groups are compared: Doxazosin plus Placebo and Doxazosin plus Sildenafil 50 mg. The graph displays downward and upward trends in SBP change over an 8-hour period for both groups.*

FDA Label Image

Sildenafilfig4 (Sildenafilfig4)

A line graph showing blood pressure changes (mmHg) over time (hours) after dosing with either Doxazosin plus Sildenafil 100 mg or Doxazosin plus placebo. The graph compares the blood pressure response up to 8 hours post-dose for both treatment groups.*

FDA Label Image

Sildenafilfig5 (Sildenafilfig5)

A plasma concentration versus time line graph showing the pharmacokinetic profile of sildenafil after oral administration of a commercial tablet. The x-axis represents time post dose in hours (0 to 24), and the y-axis represents plasma concentration in ng/mL (0 to 500). The curve rises sharply to a peak around 1 hour, then declines gradually to near zero by 24 hours.*

FDA Label Image

Sildenafilfog6a (Sildenafilfog6a)

A bar chart depicting the percentage of patients at endpoint categorized by scores from 0 to 5. Each score is represented by a distinct bar, displaying the frequency distribution of patients' outcomes in the study related to Sildenafil.*

FDA Label Image

Sildenafilfog6b (Sildenafilfog6b)

Bar chart depicting the percentage of patients at endpoint across six categories labeled 0 through 5. The y-axis represents the percentage of patients, ranging from 0 to 80%. Different shaded bars represent each category with a legend indicating categories from 0 to 5.*

FDA Label Image

Sildenafilfig7 (Sildenafilfig7)

Bar graph depicting the percentage of patients reporting improvement by treatment group. Groups compared include Placebo (24%, n=463) and Sildenafil Tablets at doses of 25 mg (63%, n=214), 50 mg (74%, n=391), and 100 mg (82%, n=380). The graph shows increasing percentages of improvement with higher Sildenafil doses. The overall treatment p-value is less than 0.0001.*

FDA Label Image

Sildenafilcamberlogo (Sildenafilcamberlogo)

FDA Label Image

Sildenafil25mg30slabel (Sildenafil25mg30slabel)

Packaging label for Sildenafil Tablets, USP 25 mg by Camber Pharmaceuticals, Inc. The label states the product contains 30 film-coated tablets and highlights storage instructions, dosage reference, manufacturer details, and a barcode. The label also notes manufacturing by Hetero Labs Limited, India.*

FDA Label Image

Sildenafil50mg30slabel (Sildenafil50mg30slabel)

Sildenafil Tablets, USP 50 mg film-coated tablet label from Camber Pharmaceuticals, Inc., containing 30 tablets. The label includes dosage, storage instructions, manufacturer information, a barcode, and an NDC number 31722-710-30. It specifies the tablet contains sildenafil citrate equivalent to 50 mg sildenafil and is for prescription use only.*

FDA Label Image

Sildenafil100mg30slabel (Sildenafil100mg30slabel)

Label for Sildenafil Tablets USP 100 mg, film-coated oral tablets. The label indicates the product contains 30 tablets and is manufactured for Camber Pharmaceuticals, Inc. Storage instructions and contact information are included. The label also shows a barcode and mentions the manufacturer as Hetero Labs Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.